{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T06:11:40Z","timestamp":1790403100297,"version":"4.1.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009780","name":"Region Sk\u00e5ne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.nbd.2019.104509","type":"journal-article","created":{"date-parts":[[2019,6,14]],"date-time":"2019-06-14T21:25:11Z","timestamp":1560547511000},"page":"104509","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"special_numbering":"C","title":["Proteomic signatures of brain regions affected by tau pathology in early and late stages of Alzheimer's disease"],"prefix":"10.1016","volume":"130","author":[{"given":"Clarissa Ferolla","family":"Mendon\u00e7a","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Kuras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e1bio C\u00e9sar Sousa","family":"Nogueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indira","family":"Pl\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tibor","family":"Hortob\u00e1gyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e1szl\u00f3","family":"Csiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikl\u00f3s","family":"Palkovits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9va","family":"Renner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter","family":"D\u00f6me","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gy\u00f6rgy","family":"Marko-Varga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilberto B.","family":"Domont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda","family":"Rezeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2019.104509_bb0005","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jalz.2017.02.001","article-title":"2017 Alzheimer's disease facts and figures","volume":"13","author":"Alzheimer's Association, A. S","year":"2017","journal-title":"Alzheimer's & Dementia"},{"key":"10.1016\/j.nbd.2019.104509_bb0010","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1093\/brain\/awq258","article-title":"Concerted changes in transcripts in the prefrontal cortex precede neuropathology in Alzheimer's disease","volume":"133","author":"Bossers","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2019.104509_bb0015","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2019.104509_bb0020","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.1074\/jbc.M110.151084","article-title":"Apolipoprotein E4 domain interaction mediates detrimental effects on mitochondria and is a potential therapeutic target for Alzheimer disease","volume":"286","author":"Chen","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2019.104509_bb0025","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science."},{"key":"10.1016\/j.nbd.2019.104509_bb0030","doi-asserted-by":"crossref","first-page":"10966","DOI":"10.1073\/pnas.191044198","article-title":"Prediction of cognitive decline in normal elderly subjects with 2-[18F]fluoro-2-deoxy-D-glucose\/positron-emission tomography (FDG\/PET)","volume":"98","author":"de Leon","year":"2001","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.nbd.2019.104509_bb0035","doi-asserted-by":"crossref","first-page":"9171","DOI":"10.1523\/JNEUROSCI.3040-05.2005","article-title":"Ribosome dysfunction is an early event in Alzheimer's disease","volume":"25","author":"Ding","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2019.104509_bb0040","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1600947","article-title":"A protein homeostasis signature in healthy brains recapitulates tissue vulnerability to Alzheimers disease","volume":"2","author":"Freer","year":"2016","journal-title":"Sci. Adv."},{"key":"10.1016\/j.nbd.2019.104509_bb0045","first-page":"15","article-title":"Altered mechanisms of protein synthesis in frontal cortex in Alzheimer disease and a mouse model","volume":"6","author":"Garcia-Esparcia","year":"2017","journal-title":"Am. J. Neurodegener. Dis."},{"key":"10.1016\/j.nbd.2019.104509_bb0050","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1074\/mcp.M115.050724","article-title":"The human tau Interactome: binding to the Ribonucleoproteome, and impaired binding of the proline-to-leucine mutant at position 301 (P301L) to chaperones and the proteasome","volume":"14","author":"Gunawardana","year":"2015","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.nbd.2019.104509_bb0055","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.bbr.2016.05.007","article-title":"Transcriptional signatures of brain aging and Alzheimer's disease: what are our rodent models telling us?","volume":"322","author":"Hargis","year":"2017","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.nbd.2019.104509_bb0060","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/bpa.12335","article-title":"Altered machinery of protein synthesis in Alzheimer's: from the nucleolus to the ribosome","volume":"26","author":"Hern\u00e1ndez-Ortega","year":"2015","journal-title":"Brain Pathol."},{"key":"10.1016\/j.nbd.2019.104509_bb0065","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jalz.2015.11.002","article-title":"Profiling the human hippocampal proteome at all pathologic stages of Alzheimer's disease","volume":"12","author":"Hondius","year":"2016","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nbd.2019.104509_bb0070","doi-asserted-by":"crossref","DOI":"10.1186\/s13195-017-0252-z","article-title":"Analyzing the genes related to Alzheimer's disease via a network and pathway-based approach","volume":"9","author":"Hu","year":"2017","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.nbd.2019.104509_bb0075","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.cell.2016.12.044","article-title":"ApoE2, ApoE3, and ApoE4 differentially stimulate APP transcription and A\u03b2 secretion","volume":"168","author":"Huang","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2019.104509_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","article-title":"National Institute on aging\u2013Alzheimer's association guidelines for the neuropathologic assessment of Alzheimer's disease","volume":"8","author":"Hyman","year":"2012","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nbd.2019.104509_bb0085","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3233\/JAD-150348","article-title":"Human ApoE isoforms differentially modulate glucose and amyloid metabolic pathways in female brain: evidence of the mechanism of neuroprotection by ApoE2 and implications for Alzheimer's disease prevention and early intervention","volume":"48","author":"Keeney","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2019.104509_bb0090","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13024-017-0234-4","article-title":"Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics","volume":"13","author":"Kim","year":"2018","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2019.104509_bb0095","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-09481-x","article-title":"Olfactory bulb neuroproteomics reveals a chronological perturbation of survival routes and a disruption of prohibitin complex during Alzheimer's disease progression","volume":"7","author":"Lach\u00e9n-Montes","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2019.104509_bb0100","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1002\/emmm.201201974","article-title":"Alteration of the microRNA network during the progression of Alzheimer's disease","volume":"5","author":"Lau","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.nbd.2019.104509_bb0105","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2016.296","article-title":"Glucose deficit triggers tau pathology and synaptic dysfunction in a tauopathy mouse model","volume":"7","author":"Lauretti","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.nbd.2019.104509_bb0110","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1152\/physiolgenomics.00208.2006","article-title":"Gene expression profiles in anatomically and functionally distinct regions of the normal aged human brain","volume":"28","author":"Liang","year":"2007","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.nbd.2019.104509_bb0115","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1073\/pnas.0709259105","article-title":"Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons","volume":"105","author":"Liang","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.nbd.2019.104509_bb0120","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-10233-0","article-title":"Amyloid precursor protein drives down-regulation of mitochondrial oxidative phosphorylation independent of amyloid beta","volume":"7","author":"Lopez Sanchez","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2019.104509_bb0125","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1084\/jem.20161731","article-title":"Tau deletion promotes brain insulin resistance","volume":"214","author":"Marciniak","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.nbd.2019.104509_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002750","article-title":"iTRAQ analysis of complex proteome alterations in 3xTgAD Alzheimer's mice: understanding the Interface between physiology and disease","volume":"3","author":"Martin","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.nbd.2019.104509_bb0135","doi-asserted-by":"crossref","first-page":"15056","DOI":"10.1038\/nrdp.2015.56","article-title":"Alzheimer's disease","author":"Masters","year":"2015","journal-title":"Nat. Rev. Disease Prim."},{"key":"10.1016\/j.nbd.2019.104509_bb0140","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.celrep.2014.12.041","article-title":"A genome-wide gene-expression analysis and database in transgenic mice during development of amyloid or tau pathology","volume":"10","author":"Matarin","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.nbd.2019.104509_bb0145","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1021\/acs.jproteome.9b00004","article-title":"Proteomic atlas of the human brain in Alzheimer's disease","volume":"18","author":"McKetney","year":"2019","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.nbd.2019.104509_bb0150","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1523\/JNEUROSCI.3029-15.2016","article-title":"Pathological tau promotes neuronal damage by impairing ribosomal function and decreasing protein synthesis","volume":"36","author":"Meier","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2019.104509_bb0155","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2014.35","article-title":"Genes associated with the progression of neurofibrillary tangles in Alzheimer's disease","volume":"4","author":"Miyashita","year":"2014","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.nbd.2019.104509_bb0160","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s40336-013-0026-y","article-title":"Glucose metabolism in normal aging and Alzheimer's disease: methodological and physiological considerations for PET studies","volume":"1","author":"Mosconi","year":"2013","journal-title":"Clin. Transl. Imaging"},{"key":"10.1016\/j.nbd.2019.104509_bb0165","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.neurobiolaging.2006.12.008","article-title":"Hippocampal hypometabolism predicts cognitive decline from normal aging","volume":"29","author":"Mosconi","year":"2008","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2019.104509_bb0170","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1074\/mcp.R115.053330","article-title":"Neurodegeneration and Alzheimer's disease (AD). What can proteomics tell us about the Alzheimer's brain?","volume":"15","author":"Moya-Alvarado","year":"2016","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.nbd.2019.104509_bb0175","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1097\/nen.0b013e31815c5efb","article-title":"Clinicopathologic correlations in a large Alzheimer disease center autopsy cohort","volume":"66","author":"Nelson","year":"2007","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2019.104509_bb0180","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.neuron.2008.10.047","article-title":"Phosphorylation of the translation initiation factor eIF2\u03b1 increases BACE1 levels and promotes Amyloidogenesis","volume":"60","author":"O'Connor","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2019.104509_bb0185","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/0006-8993(73)90290-4","article-title":"Isolated removal of hypothalamic or other brain nuclei of the rat","volume":"59","author":"Palkovits","year":"1973","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2019.104509_bb0190","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00401-013-1215-5","article-title":"Soluble pathological tau in the entorhinal cortex leads to presynaptic deficits in an early Alzheimer's disease model","volume":"127","author":"Polydoro","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2019.104509_bb0195","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/nrn2719","article-title":"Evolution of the neocortex: a perspective from developmental biology","volume":"10","author":"Rakic","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2019.104509_bb0200","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.euprot.2015.07.012","article-title":"Quantification of total apolipoprotein E and its specific isoforms in cerebrospinal fluid and blood in Alzheimer's disease and other neurodegenerative diseases","volume":"8","author":"Rezeli","year":"2015","journal-title":"EuPA Open Proteom."},{"key":"10.1016\/j.nbd.2019.104509_bb0205","doi-asserted-by":"crossref","first-page":"20057","DOI":"10.1073\/pnas.0905529106","article-title":"Amyloid- and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice","volume":"106","author":"Rhein","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.nbd.2019.104509_bb0210","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1016\/j.celrep.2017.11.009","article-title":"Amyloid accumulation drives proteome-wide alterations in mouse models of Alzheimer's disease-like pathology","volume":"21","author":"Savas","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.nbd.2019.104509_bb0215","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.neurobiolaging.2005.09.012","article-title":"Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment","volume":"27","author":"Scheff","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2019.104509_bb0220","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/1615-9861(200111)1:12<1519::AID-PROT1519>3.0.CO;2-L","article-title":"Proteomic analysis of the brain in Alzheimer's disease: molecular phenotype of a complex disease process","volume":"1","author":"Schonberger","year":"2001","journal-title":"Proteomics"},{"key":"10.1016\/j.nbd.2019.104509_bb0225","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.cels.2016.11.006","article-title":"A multi-network approach identifies protein-specific co-expression in asymptomatic and symptomatic Alzheimer's disease","volume":"4","author":"Seyfried","year":"2017","journal-title":"Cell Syst."},{"key":"10.1016\/j.nbd.2019.104509_bb0230","doi-asserted-by":"crossref","first-page":"6159","DOI":"10.1021\/pr300808h","article-title":"Longitudinal characterization of the brain proteomes for the Tg2576 amyloid mouse model using shotgun based mass spectrometry","volume":"11","author":"Shevchenko","year":"2012","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.nbd.2019.104509_bb0235","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature24016","article-title":"ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy","volume":"549","author":"Shi","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2019.104509_bb0240","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.3233\/JAD-170274","article-title":"Accuracy of clinical diagnosis of dementia with Lewy bodies versus neuropathology","volume":"59","author":"Skogseth","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2019.104509_bb0245","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1146\/annurev.neuro.27.070203.144130","article-title":"The medial temporal lobe","volume":"27","author":"Squire","year":"2004","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2019.104509_bb0250","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1089\/ars.2009.2810","article-title":"Redox proteomic analysis of carbonylated brain proteins in mild cognitive impairment and early Alzheimer's disease","volume":"12","author":"Sultana","year":"2010","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.nbd.2019.104509_bb0255","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/ana.410300410","article-title":"Physical basis of cognitive alterations in alzheimer's disease: synapse loss is the major correlate of cognitive impairment","volume":"30","author":"Terry","year":"1991","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2019.104509_bb0260","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","article-title":"Phases of A\u03b2-deposition in the human brain and its relevance for the development of AD","volume":"58","author":"Thal","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2019.104509_bb0265","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1523\/JNEUROSCI.3562-15.2016","article-title":"Direct Transcriptional effects of Apolipoprotein E","volume":"36","author":"Theendakara","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2019.104509_bb0270","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3233\/JAD-150417","article-title":"Quantitative Phosphoproteomic analyses of the inferior parietal lobule from three different pathological stages of Alzheimer's disease","volume":"49","author":"Triplett","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2019.104509_bb0275","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1021\/pr1009096","article-title":"Protein Array based Interactome analysis of amyloid-\u03b2 indicates an inhibition of protein translation","volume":"10","author":"Virok","year":"2011","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.nbd.2019.104509_bb0280","doi-asserted-by":"crossref","first-page":"D447","DOI":"10.1093\/nar\/gkv1145","article-title":"2016 update of the PRIDE database and its related tools","volume":"44","author":"Vizca\u00edno","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.nbd.2019.104509_bb0285","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/416535a","article-title":"Naturally secreted oligomers of amyloid \u03b2 protein potently inhibit hippocampal long-term potentiation in vivo","volume":"416","author":"Walsh","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2019.104509_bb0290","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nmeth.1322","article-title":"Universal sample preparation method for proteome analysis","volume":"6","author":"Wisniewski","year":"2009","journal-title":"Nat. Methods"},{"key":"10.1016\/j.nbd.2019.104509_bb0295","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s42003-018-0254-9","article-title":"Regional protein expression in human Alzheimer's brain correlates with disease severity","volume":"2","author":"Xu","year":"2019","journal-title":"Commun. Biol."},{"key":"10.1016\/j.nbd.2019.104509_bb0300","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neuron.2007.01.010","article-title":"Synapse loss and microglial activation precede tangles in a P301S Tauopathy mouse model","volume":"53","author":"Yoshiyama","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2019.104509_bb0305","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1146\/annurev-neuro-071013-014300","article-title":"Apolipoprotein E in Alzheimer's disease: an update","volume":"37","author":"Yu","year":"2014","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2019.104509_bb0310","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s11064-013-1210-1","article-title":"Differential expression of proteins in brain regions of Alzheimer's disease patients","volume":"39","author":"Zahid","year":"2014","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.nbd.2019.104509_bb0315","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.6254","article-title":"Olfactory bulb proteome dynamics during the progression of sporadic Alzheimer's disease: identification of common and distinct olfactory targets across Alzheimer-related co-pathologies","volume":"6","author":"Zelaya","year":"2015","journal-title":"Oncotarget"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096999611930169X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096999611930169X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:16:48Z","timestamp":1760851008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096999611930169X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":63,"alternative-id":["S096999611930169X"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2019.104509","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proteomic signatures of brain regions affected by tau pathology in early and late stages of Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2019.104509","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104509"}}